Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children with Cancer

S
Sandeep Batra, MD

Primary Investigator

Administratively Closed
1 years - 21 years
All
Phase N/A
15 participants needed
3 Locations

Brief description of study

What is the purpose of this study?
This research trial studies neuropsychological (learning, remembering or thinking) and behavioral testing in younger patients with cancer. Collecting information over time from a series of tests may help doctors develop effective tests to measure neuropsychological and behavioral function of patients with cancer.

THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent with most oncology trials, patients are not actively “recruited,” but are screened by their physician for appropriate clinical trial(s) at the time of their routine clinic visit. Occasionally, a patient may be a self-referral or physician referral, but are still screened for appropriate clinical trials at the time of their routine clinic visit. PI and staff may send copies of relevant consent forms to these patients to look over prior to actually consenting or enrolling them. This may take place at the patient's visit at which the consent is presented or the patient's next visit to the outpatient hematology/oncology clinic.

Interested in participating? For more information about this research study or other cancer-related clinical trials at IU Simon Comprehensive Cancer Center, please contact:
IU Clinical Trials Office 
Phone: (317) 278-5632

Detailed description of study

What will happen during the study?
  • Parent and child participants complete the COG Standard Neuropsychological and Behavioral Battery at approximately 9, 30, and 60 months post-diagnosis in a 1-2 hour testing session conducted by a neuropsychologist or psychologist. 
  • The Battery consists of measures of intelligence, processing speed, attention, memory, language preference, behavioral/social/emotional function, executive function, adaptive function, and quality of life.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Childhood Malignant Neoplasm
  • Age: 1 years - 21 years
  • Gender: All

Inclusion Criteria
  • Must be currently enrolled on a COG therapeutic study that aims to examine neuropsychological, social, emotional, and/or behavioral functioning
  • Patient must have receptive and expressive English language skills
Exclusion Criteria
  • Patients with a history of severe or profound mental retardation

Updated on 13 Aug 2024. Study ID: 1106005959, PHO-COG-FALLON-ALTE07C1, NCT00772200

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the Study Team